Compositions capable of reducing elevated blood urea concentration
USRE43279E1 · kind E1 · reissue
0Cited by
40References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 17, 2011 |
| Grant date | Mar 27, 2012 |
| Priority date | — |
| Expiry date | Mar 17, 2031 |
Classification
- Technology area (CPC —)General
Abstract
The invention includes a method of reducing urea concentration in a subject's serum. Such a method comprises administering to the subject (e.g., a mammal such as a human) a composition comprising an oligopeptide (or oligopeptides) having activity in reducing urea concentration in the subject's serum as determined by a mouse renal reperfusion test, wherein the oligopeptide comprises the sequence AQG or MTRV (SEQ ID NO:1), AQGV (SEQ ID NO:2) or LAGV (SEQ ID NO:4).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.